Trodelvy® Added as Preferred Regimen Within First-Line Metastatic Triple-Negative Breast Cancer

U.S. FDA Approves Trodelvy® for First-Line Treatment of Metastatic Triple-Negative Breast Cancer

A Revolution in Breast Cancer Prevention Is Underway—With AI Mammogram-Based Risk Assessment Starting at 35

The Walk Is Not a Metaphor: Sisters Network and the Work of Keeping Black Women Alive